nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.131	0.195	CbGbCtD
Trimethoprim—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0911	0.136	CbGbCtD
Trimethoprim—CYP2C8—Progesterone—uterine cancer	0.0866	0.129	CbGbCtD
Trimethoprim—CYP2C9—Progesterone—uterine cancer	0.0604	0.09	CbGbCtD
Trimethoprim—ABCB1—Progesterone—uterine cancer	0.0586	0.0873	CbGbCtD
Trimethoprim—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.053	0.079	CbGbCtD
Trimethoprim—ABCB1—Dactinomycin—uterine cancer	0.0465	0.0692	CbGbCtD
Trimethoprim—CYP2C8—Etoposide—uterine cancer	0.0387	0.0577	CbGbCtD
Trimethoprim—CYP3A4—Progesterone—uterine cancer	0.0351	0.0523	CbGbCtD
Trimethoprim—ABCB1—Etoposide—uterine cancer	0.0262	0.0391	CbGbCtD
Trimethoprim—ABCB1—Doxorubicin—uterine cancer	0.0179	0.0266	CbGbCtD
Trimethoprim—CYP3A4—Etoposide—uterine cancer	0.0157	0.0234	CbGbCtD
Trimethoprim—CYP3A4—Doxorubicin—uterine cancer	0.0107	0.016	CbGbCtD
Trimethoprim—DHFR—myometrium—uterine cancer	0.00318	0.0622	CbGeAlD
Trimethoprim—TYMS—uterine cervix—uterine cancer	0.0025	0.0489	CbGeAlD
Trimethoprim—DHFR—uterine cervix—uterine cancer	0.00247	0.0484	CbGeAlD
Trimethoprim—TYMS—smooth muscle tissue—uterine cancer	0.00243	0.0475	CbGeAlD
Trimethoprim—DHFR—decidua—uterine cancer	0.00236	0.0461	CbGeAlD
Trimethoprim—DHFR—renal system—uterine cancer	0.00231	0.0453	CbGeAlD
Trimethoprim—TYMS—Podofilox—Etoposide—uterine cancer	0.00228	0.531	CbGdCrCtD
Trimethoprim—TYMS—endometrium—uterine cancer	0.00226	0.0442	CbGeAlD
Trimethoprim—DHFR—endometrium—uterine cancer	0.00224	0.0438	CbGeAlD
Trimethoprim—TYMS—mammalian vulva—uterine cancer	0.00219	0.0427	CbGeAlD
Trimethoprim—DHFR—mammalian vulva—uterine cancer	0.00216	0.0423	CbGeAlD
Trimethoprim—DHFR—uterus—uterine cancer	0.00206	0.0403	CbGeAlD
Trimethoprim—TYMS—female reproductive system—uterine cancer	0.00187	0.0366	CbGeAlD
Trimethoprim—DHFR—female reproductive system—uterine cancer	0.00185	0.0362	CbGeAlD
Trimethoprim—TYMS—female gonad—uterine cancer	0.0017	0.0333	CbGeAlD
Trimethoprim—TYMS—vagina—uterine cancer	0.00169	0.0331	CbGeAlD
Trimethoprim—DHFR—female gonad—uterine cancer	0.00169	0.033	CbGeAlD
Trimethoprim—DHFR—vagina—uterine cancer	0.00168	0.0328	CbGeAlD
Trimethoprim—TYMS—Danazol—Progesterone—uterine cancer	0.00117	0.273	CbGdCrCtD
Trimethoprim—CYP2C8—renal system—uterine cancer	0.00115	0.0225	CbGeAlD
Trimethoprim—CYP2C8—endometrium—uterine cancer	0.00111	0.0217	CbGeAlD
Trimethoprim—TYMS—lymph node—uterine cancer	0.0011	0.0214	CbGeAlD
Trimethoprim—DHFR—lymph node—uterine cancer	0.00108	0.0212	CbGeAlD
Trimethoprim—CYP2C8—female reproductive system—uterine cancer	0.00092	0.018	CbGeAlD
Trimethoprim—TYMS—Levonorgestrel—Progesterone—uterine cancer	0.000842	0.196	CbGdCrCtD
Trimethoprim—CYP2C8—vagina—uterine cancer	0.000832	0.0163	CbGeAlD
Trimethoprim—CYP2C9—female reproductive system—uterine cancer	0.000818	0.016	CbGeAlD
Trimethoprim—CYP3A4—renal system—uterine cancer	0.000778	0.0152	CbGeAlD
Trimethoprim—ABCB1—myometrium—uterine cancer	0.000757	0.0148	CbGeAlD
Trimethoprim—CYP3A4—female reproductive system—uterine cancer	0.000623	0.0122	CbGeAlD
Trimethoprim—ABCB1—epithelium—uterine cancer	0.000594	0.0116	CbGeAlD
Trimethoprim—ABCB1—uterine cervix—uterine cancer	0.000589	0.0115	CbGeAlD
Trimethoprim—ABCB1—decidua—uterine cancer	0.000561	0.011	CbGeAlD
Trimethoprim—ABCB1—renal system—uterine cancer	0.000551	0.0108	CbGeAlD
Trimethoprim—ABCB1—endometrium—uterine cancer	0.000533	0.0104	CbGeAlD
Trimethoprim—ABCB1—mammalian vulva—uterine cancer	0.000515	0.0101	CbGeAlD
Trimethoprim—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000512	0.00281	CcSEcCtD
Trimethoprim—Glossitis—Doxorubicin—uterine cancer	0.000512	0.00281	CcSEcCtD
Trimethoprim—Pneumonia—Etoposide—uterine cancer	0.000512	0.00281	CcSEcCtD
Trimethoprim—Infestation—Etoposide—uterine cancer	0.000509	0.00279	CcSEcCtD
Trimethoprim—Infestation NOS—Etoposide—uterine cancer	0.000509	0.00279	CcSEcCtD
Trimethoprim—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000506	0.00278	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.000504	0.00277	CcSEcCtD
Trimethoprim—Urticaria—Progesterone—uterine cancer	0.000504	0.00277	CcSEcCtD
Trimethoprim—Dyskinesia—Doxorubicin—uterine cancer	0.000502	0.00275	CcSEcCtD
Trimethoprim—Abdominal pain—Progesterone—uterine cancer	0.000501	0.00275	CcSEcCtD
Trimethoprim—Body temperature increased—Progesterone—uterine cancer	0.000501	0.00275	CcSEcCtD
Trimethoprim—Hyperkalaemia—Epirubicin—uterine cancer	0.000501	0.00275	CcSEcCtD
Trimethoprim—Renal failure—Etoposide—uterine cancer	0.0005	0.00274	CcSEcCtD
Trimethoprim—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.0005	0.00274	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Etoposide—uterine cancer	0.000499	0.00274	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000496	0.00272	CcSEcCtD
Trimethoprim—Stomatitis—Etoposide—uterine cancer	0.000496	0.00272	CcSEcCtD
Trimethoprim—Leukopenia—Dactinomycin—uterine cancer	0.000492	0.0027	CcSEcCtD
Trimethoprim—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000491	0.0027	CcSEcCtD
Trimethoprim—ABCB1—uterus—uterine cancer	0.000491	0.0096	CbGeAlD
Trimethoprim—Hepatobiliary disease—Etoposide—uterine cancer	0.000481	0.00264	CcSEcCtD
Trimethoprim—Aplastic anaemia—Epirubicin—uterine cancer	0.000479	0.00263	CcSEcCtD
Trimethoprim—Agranulocytosis—Etoposide—uterine cancer	0.000475	0.00261	CcSEcCtD
Trimethoprim—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000474	0.0026	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00047	0.00258	CcSEcCtD
Trimethoprim—Myalgia—Dactinomycin—uterine cancer	0.000468	0.00257	CcSEcCtD
Trimethoprim—Hypersensitivity—Progesterone—uterine cancer	0.000467	0.00256	CcSEcCtD
Trimethoprim—Hyperkalaemia—Doxorubicin—uterine cancer	0.000463	0.00254	CcSEcCtD
Trimethoprim—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000457	0.00251	CcSEcCtD
Trimethoprim—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000454	0.00249	CcSEcCtD
Trimethoprim—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000454	0.00249	CcSEcCtD
Trimethoprim—Urinary tract disorder—Etoposide—uterine cancer	0.000451	0.00248	CcSEcCtD
Trimethoprim—Pruritus—Progesterone—uterine cancer	0.000449	0.00246	CcSEcCtD
Trimethoprim—Urethral disorder—Etoposide—uterine cancer	0.000448	0.00246	CcSEcCtD
Trimethoprim—Aplastic anaemia—Doxorubicin—uterine cancer	0.000443	0.00243	CcSEcCtD
Trimethoprim—ABCB1—female reproductive system—uterine cancer	0.000441	0.00863	CbGeAlD
Trimethoprim—Thrombocytopenia—Dactinomycin—uterine cancer	0.000439	0.00241	CcSEcCtD
Trimethoprim—Diarrhoea—Progesterone—uterine cancer	0.000434	0.00238	CcSEcCtD
Trimethoprim—Erythema multiforme—Etoposide—uterine cancer	0.000432	0.00237	CcSEcCtD
Trimethoprim—Anorexia—Dactinomycin—uterine cancer	0.000427	0.00235	CcSEcCtD
Trimethoprim—Eye disorder—Etoposide—uterine cancer	0.000427	0.00234	CcSEcCtD
Trimethoprim—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000423	0.00232	CcSEcCtD
Trimethoprim—Photosensitivity—Epirubicin—uterine cancer	0.000421	0.00231	CcSEcCtD
Trimethoprim—Dizziness—Progesterone—uterine cancer	0.000419	0.0023	CcSEcCtD
Trimethoprim—Vascular purpura—Epirubicin—uterine cancer	0.000414	0.00227	CcSEcCtD
Trimethoprim—Immune system disorder—Etoposide—uterine cancer	0.000412	0.00226	CcSEcCtD
Trimethoprim—Mediastinal disorder—Etoposide—uterine cancer	0.000412	0.00226	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000408	0.00224	CcSEcCtD
Trimethoprim—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000407	0.00223	CcSEcCtD
Trimethoprim—Vomiting—Progesterone—uterine cancer	0.000403	0.00221	CcSEcCtD
Trimethoprim—ABCB1—female gonad—uterine cancer	0.000402	0.00785	CbGeAlD
Trimethoprim—Rash—Progesterone—uterine cancer	0.0004	0.00219	CcSEcCtD
Trimethoprim—Dermatitis—Progesterone—uterine cancer	0.0004	0.00219	CcSEcCtD
Trimethoprim—ABCB1—vagina—uterine cancer	0.000399	0.0078	CbGeAlD
Trimethoprim—Headache—Progesterone—uterine cancer	0.000397	0.00218	CcSEcCtD
Trimethoprim—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000393	0.00216	CcSEcCtD
Trimethoprim—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000392	0.00215	CcSEcCtD
Trimethoprim—Photosensitivity—Doxorubicin—uterine cancer	0.00039	0.00214	CcSEcCtD
Trimethoprim—Decreased appetite—Dactinomycin—uterine cancer	0.00039	0.00214	CcSEcCtD
Trimethoprim—Renal impairment—Epirubicin—uterine cancer	0.000389	0.00213	CcSEcCtD
Trimethoprim—Dermatitis bullous—Epirubicin—uterine cancer	0.000387	0.00213	CcSEcCtD
Trimethoprim—Purpura—Epirubicin—uterine cancer	0.000384	0.00211	CcSEcCtD
Trimethoprim—Vascular purpura—Doxorubicin—uterine cancer	0.000383	0.0021	CcSEcCtD
Trimethoprim—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00038	0.00209	CcSEcCtD
Trimethoprim—Hypoglycaemia—Epirubicin—uterine cancer	0.000379	0.00208	CcSEcCtD
Trimethoprim—Lethargy—Epirubicin—uterine cancer	0.000378	0.00207	CcSEcCtD
Trimethoprim—Nausea—Progesterone—uterine cancer	0.000377	0.00207	CcSEcCtD
Trimethoprim—Hyponatraemia—Epirubicin—uterine cancer	0.000372	0.00204	CcSEcCtD
Trimethoprim—Feeling abnormal—Dactinomycin—uterine cancer	0.000369	0.00203	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000367	0.00201	CcSEcCtD
Trimethoprim—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000365	0.00201	CcSEcCtD
Trimethoprim—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000363	0.00199	CcSEcCtD
Trimethoprim—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000362	0.00199	CcSEcCtD
Trimethoprim—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000362	0.00199	CcSEcCtD
Trimethoprim—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00036	0.00198	CcSEcCtD
Trimethoprim—Renal impairment—Doxorubicin—uterine cancer	0.00036	0.00197	CcSEcCtD
Trimethoprim—Dermatitis bullous—Doxorubicin—uterine cancer	0.000358	0.00197	CcSEcCtD
Trimethoprim—Vertigo—Etoposide—uterine cancer	0.000357	0.00196	CcSEcCtD
Trimethoprim—Leukopenia—Etoposide—uterine cancer	0.000356	0.00195	CcSEcCtD
Trimethoprim—Purpura—Doxorubicin—uterine cancer	0.000355	0.00195	CcSEcCtD
Trimethoprim—Abdominal pain—Dactinomycin—uterine cancer	0.000354	0.00195	CcSEcCtD
Trimethoprim—Body temperature increased—Dactinomycin—uterine cancer	0.000354	0.00195	CcSEcCtD
Trimethoprim—Hypoglycaemia—Doxorubicin—uterine cancer	0.000351	0.00193	CcSEcCtD
Trimethoprim—Loss of consciousness—Etoposide—uterine cancer	0.000349	0.00192	CcSEcCtD
Trimethoprim—Lethargy—Doxorubicin—uterine cancer	0.000349	0.00192	CcSEcCtD
Trimethoprim—Ataxia—Epirubicin—uterine cancer	0.000348	0.00191	CcSEcCtD
Trimethoprim—Cough—Etoposide—uterine cancer	0.000347	0.0019	CcSEcCtD
Trimethoprim—Convulsion—Etoposide—uterine cancer	0.000344	0.00189	CcSEcCtD
Trimethoprim—Hyponatraemia—Doxorubicin—uterine cancer	0.000344	0.00189	CcSEcCtD
Trimethoprim—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000341	0.00187	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000336	0.00184	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000333	0.00183	CcSEcCtD
Trimethoprim—Hypersensitivity—Dactinomycin—uterine cancer	0.00033	0.00181	CcSEcCtD
Trimethoprim—Confusional state—Etoposide—uterine cancer	0.000327	0.0018	CcSEcCtD
Trimethoprim—Anaphylactic shock—Etoposide—uterine cancer	0.000324	0.00178	CcSEcCtD
Trimethoprim—Ataxia—Doxorubicin—uterine cancer	0.000322	0.00177	CcSEcCtD
Trimethoprim—Thrombocytopenia—Etoposide—uterine cancer	0.000318	0.00174	CcSEcCtD
Trimethoprim—Eosinophilia—Epirubicin—uterine cancer	0.000317	0.00174	CcSEcCtD
Trimethoprim—Skin disorder—Etoposide—uterine cancer	0.000315	0.00173	CcSEcCtD
Trimethoprim—Pancreatitis—Epirubicin—uterine cancer	0.000314	0.00172	CcSEcCtD
Trimethoprim—Anorexia—Etoposide—uterine cancer	0.000309	0.0017	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000308	0.00169	CcSEcCtD
Trimethoprim—Diarrhoea—Dactinomycin—uterine cancer	0.000307	0.00168	CcSEcCtD
Trimethoprim—Pancytopenia—Epirubicin—uterine cancer	0.000304	0.00167	CcSEcCtD
Trimethoprim—Neutropenia—Epirubicin—uterine cancer	0.000299	0.00164	CcSEcCtD
Trimethoprim—Eosinophilia—Doxorubicin—uterine cancer	0.000293	0.00161	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Epirubicin—uterine cancer	0.000292	0.0016	CcSEcCtD
Trimethoprim—Pancreatitis—Doxorubicin—uterine cancer	0.00029	0.00159	CcSEcCtD
Trimethoprim—Dyspnoea—Etoposide—uterine cancer	0.000289	0.00159	CcSEcCtD
Trimethoprim—Pneumonia—Epirubicin—uterine cancer	0.000287	0.00157	CcSEcCtD
Trimethoprim—Infestation—Epirubicin—uterine cancer	0.000285	0.00157	CcSEcCtD
Trimethoprim—Infestation NOS—Epirubicin—uterine cancer	0.000285	0.00157	CcSEcCtD
Trimethoprim—Vomiting—Dactinomycin—uterine cancer	0.000285	0.00156	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000283	0.00155	CcSEcCtD
Trimethoprim—Rash—Dactinomycin—uterine cancer	0.000283	0.00155	CcSEcCtD
Trimethoprim—Decreased appetite—Etoposide—uterine cancer	0.000282	0.00155	CcSEcCtD
Trimethoprim—Pancytopenia—Doxorubicin—uterine cancer	0.000281	0.00154	CcSEcCtD
Trimethoprim—Renal failure—Epirubicin—uterine cancer	0.00028	0.00154	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Etoposide—uterine cancer	0.00028	0.00154	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Epirubicin—uterine cancer	0.00028	0.00153	CcSEcCtD
Trimethoprim—Stomatitis—Epirubicin—uterine cancer	0.000278	0.00153	CcSEcCtD
Trimethoprim—Constipation—Etoposide—uterine cancer	0.000277	0.00152	CcSEcCtD
Trimethoprim—Neutropenia—Doxorubicin—uterine cancer	0.000277	0.00152	CcSEcCtD
Trimethoprim—Haematuria—Epirubicin—uterine cancer	0.000272	0.00149	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Doxorubicin—uterine cancer	0.00027	0.00148	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Epirubicin—uterine cancer	0.00027	0.00148	CcSEcCtD
Trimethoprim—Epistaxis—Epirubicin—uterine cancer	0.000269	0.00148	CcSEcCtD
Trimethoprim—Feeling abnormal—Etoposide—uterine cancer	0.000267	0.00147	CcSEcCtD
Trimethoprim—Nausea—Dactinomycin—uterine cancer	0.000266	0.00146	CcSEcCtD
Trimethoprim—Agranulocytosis—Epirubicin—uterine cancer	0.000266	0.00146	CcSEcCtD
Trimethoprim—Pneumonia—Doxorubicin—uterine cancer	0.000265	0.00146	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Etoposide—uterine cancer	0.000265	0.00146	CcSEcCtD
Trimethoprim—Infestation NOS—Doxorubicin—uterine cancer	0.000264	0.00145	CcSEcCtD
Trimethoprim—Infestation—Doxorubicin—uterine cancer	0.000264	0.00145	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000262	0.00144	CcSEcCtD
Trimethoprim—Renal failure—Doxorubicin—uterine cancer	0.000259	0.00142	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000259	0.00142	CcSEcCtD
Trimethoprim—ABCB1—lymph node—uterine cancer	0.000258	0.00505	CbGeAlD
Trimethoprim—Urticaria—Etoposide—uterine cancer	0.000258	0.00141	CcSEcCtD
Trimethoprim—Stomatitis—Doxorubicin—uterine cancer	0.000257	0.00141	CcSEcCtD
Trimethoprim—Abdominal pain—Etoposide—uterine cancer	0.000256	0.00141	CcSEcCtD
Trimethoprim—Body temperature increased—Etoposide—uterine cancer	0.000256	0.00141	CcSEcCtD
Trimethoprim—Urinary tract disorder—Epirubicin—uterine cancer	0.000253	0.00139	CcSEcCtD
Trimethoprim—Haematuria—Doxorubicin—uterine cancer	0.000252	0.00138	CcSEcCtD
Trimethoprim—Connective tissue disorder—Epirubicin—uterine cancer	0.000252	0.00138	CcSEcCtD
Trimethoprim—Urethral disorder—Epirubicin—uterine cancer	0.000251	0.00138	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Doxorubicin—uterine cancer	0.00025	0.00137	CcSEcCtD
Trimethoprim—Epistaxis—Doxorubicin—uterine cancer	0.000249	0.00137	CcSEcCtD
Trimethoprim—Agranulocytosis—Doxorubicin—uterine cancer	0.000246	0.00135	CcSEcCtD
Trimethoprim—Erythema multiforme—Epirubicin—uterine cancer	0.000242	0.00133	CcSEcCtD
Trimethoprim—Eye disorder—Epirubicin—uterine cancer	0.000239	0.00131	CcSEcCtD
Trimethoprim—Hypersensitivity—Etoposide—uterine cancer	0.000239	0.00131	CcSEcCtD
Trimethoprim—Tinnitus—Epirubicin—uterine cancer	0.000239	0.00131	CcSEcCtD
Trimethoprim—TYMS—Cell Cycle, Mitotic—RRM2—uterine cancer	0.000235	0.00258	CbGpPWpGaD
Trimethoprim—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000235	0.00257	CbGpPWpGaD
Trimethoprim—Urinary tract disorder—Doxorubicin—uterine cancer	0.000234	0.00128	CcSEcCtD
Trimethoprim—Connective tissue disorder—Doxorubicin—uterine cancer	0.000233	0.00128	CcSEcCtD
Trimethoprim—TYMS—G1/S Transition—CDKN1B—uterine cancer	0.000233	0.00255	CbGpPWpGaD
Trimethoprim—Urethral disorder—Doxorubicin—uterine cancer	0.000232	0.00127	CcSEcCtD
Trimethoprim—Immune system disorder—Epirubicin—uterine cancer	0.000231	0.00127	CcSEcCtD
Trimethoprim—Mediastinal disorder—Epirubicin—uterine cancer	0.000231	0.00127	CcSEcCtD
Trimethoprim—CYP2C9—Metapathway biotransformation—AKR1B1—uterine cancer	0.00023	0.00252	CbGpPWpGaD
Trimethoprim—Pruritus—Etoposide—uterine cancer	0.00023	0.00126	CcSEcCtD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	0.000225	0.00246	CbGpPWpGaD
Trimethoprim—Mental disorder—Epirubicin—uterine cancer	0.000224	0.00123	CcSEcCtD
Trimethoprim—Erythema multiforme—Doxorubicin—uterine cancer	0.000224	0.00123	CcSEcCtD
Trimethoprim—Erythema—Epirubicin—uterine cancer	0.000223	0.00122	CcSEcCtD
Trimethoprim—Malnutrition—Epirubicin—uterine cancer	0.000223	0.00122	CcSEcCtD
Trimethoprim—Diarrhoea—Etoposide—uterine cancer	0.000222	0.00122	CcSEcCtD
Trimethoprim—Eye disorder—Doxorubicin—uterine cancer	0.000221	0.00121	CcSEcCtD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—CDKN2A—uterine cancer	0.000221	0.00243	CbGpPWpGaD
Trimethoprim—Tinnitus—Doxorubicin—uterine cancer	0.000221	0.00121	CcSEcCtD
Trimethoprim—DHFR—Metabolism—SRD5A2—uterine cancer	0.000219	0.0024	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—NDUFB11—uterine cancer	0.000219	0.0024	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000218	0.00239	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—YWHAE—uterine cancer	0.000217	0.00237	CbGpPWpGaD
Trimethoprim—Dizziness—Etoposide—uterine cancer	0.000215	0.00118	CcSEcCtD
Trimethoprim—DHFR—Cell Cycle—MLH1—uterine cancer	0.000214	0.00235	CbGpPWpGaD
Trimethoprim—Immune system disorder—Doxorubicin—uterine cancer	0.000214	0.00117	CcSEcCtD
Trimethoprim—Mediastinal disorder—Doxorubicin—uterine cancer	0.000213	0.00117	CcSEcCtD
Trimethoprim—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000213	0.00234	CbGpPWpGaD
Trimethoprim—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000211	0.00231	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—RRM2—uterine cancer	0.00021	0.00231	CbGpPWpGaD
Trimethoprim—Mental disorder—Doxorubicin—uterine cancer	0.000208	0.00114	CcSEcCtD
Trimethoprim—CYP2C8—Metapathway biotransformation—AKR1C1—uterine cancer	0.000207	0.00227	CbGpPWpGaD
Trimethoprim—Vomiting—Etoposide—uterine cancer	0.000206	0.00113	CcSEcCtD
Trimethoprim—Malnutrition—Doxorubicin—uterine cancer	0.000206	0.00113	CcSEcCtD
Trimethoprim—Erythema—Doxorubicin—uterine cancer	0.000206	0.00113	CcSEcCtD
Trimethoprim—Agitation—Epirubicin—uterine cancer	0.000205	0.00112	CcSEcCtD
Trimethoprim—Rash—Etoposide—uterine cancer	0.000205	0.00112	CcSEcCtD
Trimethoprim—Dermatitis—Etoposide—uterine cancer	0.000204	0.00112	CcSEcCtD
Trimethoprim—DHFR—Disease—AKR1B10—uterine cancer	0.000203	0.00223	CbGpPWpGaD
Trimethoprim—Headache—Etoposide—uterine cancer	0.000203	0.00112	CcSEcCtD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	0.000201	0.0022	CbGpPWpGaD
Trimethoprim—Vertigo—Epirubicin—uterine cancer	0.0002	0.0011	CcSEcCtD
Trimethoprim—Syncope—Epirubicin—uterine cancer	0.0002	0.0011	CcSEcCtD
Trimethoprim—Leukopenia—Epirubicin—uterine cancer	0.000199	0.00109	CcSEcCtD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	0.000196	0.00215	CbGpPWpGaD
Trimethoprim—Loss of consciousness—Epirubicin—uterine cancer	0.000196	0.00108	CcSEcCtD
Trimethoprim—Cough—Epirubicin—uterine cancer	0.000194	0.00107	CcSEcCtD
Trimethoprim—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000194	0.00213	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—YWHAE—uterine cancer	0.000194	0.00212	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—SMAD3—uterine cancer	0.000193	0.00212	CbGpPWpGaD
Trimethoprim—Convulsion—Epirubicin—uterine cancer	0.000193	0.00106	CcSEcCtD
Trimethoprim—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000193	0.00212	CbGpPWpGaD
Trimethoprim—Nausea—Etoposide—uterine cancer	0.000193	0.00106	CcSEcCtD
Trimethoprim—TYMS—Metabolism—NDUFB11—uterine cancer	0.000191	0.00209	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—SRD5A2—uterine cancer	0.000191	0.00209	CbGpPWpGaD
Trimethoprim—Arthralgia—Epirubicin—uterine cancer	0.00019	0.00104	CcSEcCtD
Trimethoprim—Myalgia—Epirubicin—uterine cancer	0.00019	0.00104	CcSEcCtD
Trimethoprim—Agitation—Doxorubicin—uterine cancer	0.000189	0.00104	CcSEcCtD
Trimethoprim—Anxiety—Epirubicin—uterine cancer	0.000189	0.00104	CcSEcCtD
Trimethoprim—TYMS—Cell Cycle, Mitotic—YWHAE—uterine cancer	0.000189	0.00207	CbGpPWpGaD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000188	0.00103	CcSEcCtD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.000187	0.00205	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MLH1—uterine cancer	0.000187	0.00205	CbGpPWpGaD
Trimethoprim—Vertigo—Doxorubicin—uterine cancer	0.000185	0.00102	CcSEcCtD
Trimethoprim—Syncope—Doxorubicin—uterine cancer	0.000185	0.00101	CcSEcCtD
Trimethoprim—Leukopenia—Doxorubicin—uterine cancer	0.000185	0.00101	CcSEcCtD
Trimethoprim—Confusional state—Epirubicin—uterine cancer	0.000183	0.00101	CcSEcCtD
Trimethoprim—Anaphylactic shock—Epirubicin—uterine cancer	0.000182	0.000998	CcSEcCtD
Trimethoprim—CYP2C8—Metapathway biotransformation—GPX3—uterine cancer	0.000182	0.00199	CbGpPWpGaD
Trimethoprim—Loss of consciousness—Doxorubicin—uterine cancer	0.000181	0.000995	CcSEcCtD
Trimethoprim—Cough—Doxorubicin—uterine cancer	0.00018	0.000988	CcSEcCtD
Trimethoprim—Shock—Epirubicin—uterine cancer	0.000179	0.000982	CcSEcCtD
Trimethoprim—Convulsion—Doxorubicin—uterine cancer	0.000179	0.000981	CcSEcCtD
Trimethoprim—Nervous system disorder—Epirubicin—uterine cancer	0.000178	0.000979	CcSEcCtD
Trimethoprim—Thrombocytopenia—Epirubicin—uterine cancer	0.000178	0.000977	CcSEcCtD
Trimethoprim—Skin disorder—Epirubicin—uterine cancer	0.000177	0.00097	CcSEcCtD
Trimethoprim—Arthralgia—Doxorubicin—uterine cancer	0.000176	0.000963	CcSEcCtD
Trimethoprim—Myalgia—Doxorubicin—uterine cancer	0.000176	0.000963	CcSEcCtD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	0.000175	0.00192	CbGpPWpGaD
Trimethoprim—Anxiety—Doxorubicin—uterine cancer	0.000175	0.00096	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000174	0.000957	CcSEcCtD
Trimethoprim—Anorexia—Epirubicin—uterine cancer	0.000173	0.000952	CcSEcCtD
Trimethoprim—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000173	0.0019	CbGpPWpGaD
Trimethoprim—CYP2C8—Biological oxidations—CYP11A1—uterine cancer	0.000171	0.00188	CbGpPWpGaD
Trimethoprim—Confusional state—Doxorubicin—uterine cancer	0.00017	0.000931	CcSEcCtD
Trimethoprim—TYMS—Cell Cycle—YWHAE—uterine cancer	0.000169	0.00185	CbGpPWpGaD
Trimethoprim—CYP2C8—Metapathway biotransformation—CYP11A1—uterine cancer	0.000169	0.00185	CbGpPWpGaD
Trimethoprim—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	0.000169	0.00185	CbGpPWpGaD
Trimethoprim—DHFR—Disease—RNF43—uterine cancer	0.000169	0.00185	CbGpPWpGaD
Trimethoprim—Anaphylactic shock—Doxorubicin—uterine cancer	0.000168	0.000924	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000166	0.000909	CcSEcCtD
Trimethoprim—Shock—Doxorubicin—uterine cancer	0.000166	0.000909	CcSEcCtD
Trimethoprim—Nervous system disorder—Doxorubicin—uterine cancer	0.000165	0.000906	CcSEcCtD
Trimethoprim—Thrombocytopenia—Doxorubicin—uterine cancer	0.000165	0.000904	CcSEcCtD
Trimethoprim—Insomnia—Epirubicin—uterine cancer	0.000164	0.000903	CcSEcCtD
Trimethoprim—Skin disorder—Doxorubicin—uterine cancer	0.000163	0.000897	CcSEcCtD
Trimethoprim—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	0.000163	0.00179	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CDKN2B—uterine cancer	0.000163	0.00178	CbGpPWpGaD
Trimethoprim—Dyspnoea—Epirubicin—uterine cancer	0.000162	0.00089	CcSEcCtD
Trimethoprim—Anorexia—Doxorubicin—uterine cancer	0.00016	0.00088	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.00016	0.00176	CbGpPWpGaD
Trimethoprim—Dyspepsia—Epirubicin—uterine cancer	0.00016	0.000879	CcSEcCtD
Trimethoprim—CYP2C8—Metapathway biotransformation—AKR1C3—uterine cancer	0.000159	0.00175	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—STAR—uterine cancer	0.000158	0.00174	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—AKR1B1—uterine cancer	0.000158	0.00174	CbGpPWpGaD
Trimethoprim—Decreased appetite—Epirubicin—uterine cancer	0.000158	0.000868	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000157	0.000862	CcSEcCtD
Trimethoprim—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000157	0.00172	CbGpPWpGaD
Trimethoprim—Constipation—Epirubicin—uterine cancer	0.000156	0.000854	CcSEcCtD
Trimethoprim—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000155	0.0017	CbGpPWpGaD
Trimethoprim—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000153	0.000842	CcSEcCtD
Trimethoprim—Insomnia—Doxorubicin—uterine cancer	0.000152	0.000835	CcSEcCtD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000152	0.00167	CbGpPWpGaD
Trimethoprim—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	0.000151	0.00166	CbGpPWpGaD
Trimethoprim—Dyspnoea—Doxorubicin—uterine cancer	0.00015	0.000823	CcSEcCtD
Trimethoprim—Feeling abnormal—Epirubicin—uterine cancer	0.00015	0.000823	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Epirubicin—uterine cancer	0.000149	0.000816	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.000148	0.00163	CbGpPWpGaD
Trimethoprim—Dyspepsia—Doxorubicin—uterine cancer	0.000148	0.000813	CcSEcCtD
Trimethoprim—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	0.000148	0.00162	CbGpPWpGaD
Trimethoprim—Decreased appetite—Doxorubicin—uterine cancer	0.000146	0.000803	CcSEcCtD
Trimethoprim—DHFR—Cell Cycle—CDKN2B—uterine cancer	0.000145	0.00159	CbGpPWpGaD
Trimethoprim—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000145	0.000797	CcSEcCtD
Trimethoprim—Urticaria—Epirubicin—uterine cancer	0.000144	0.000793	CcSEcCtD
Trimethoprim—Constipation—Doxorubicin—uterine cancer	0.000144	0.00079	CcSEcCtD
Trimethoprim—Abdominal pain—Epirubicin—uterine cancer	0.000144	0.000789	CcSEcCtD
Trimethoprim—Body temperature increased—Epirubicin—uterine cancer	0.000144	0.000789	CcSEcCtD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDKN2B—uterine cancer	0.000142	0.00156	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—BIRC5—uterine cancer	0.00014	0.00154	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.00014	0.00154	CbGpPWpGaD
Trimethoprim—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	0.000139	0.00153	CbGpPWpGaD
Trimethoprim—DHFR—Disease—AKR1C1—uterine cancer	0.000139	0.00152	CbGpPWpGaD
Trimethoprim—Feeling abnormal—Doxorubicin—uterine cancer	0.000139	0.000761	CcSEcCtD
Trimethoprim—TYMS—Metabolism—STAR—uterine cancer	0.000138	0.00151	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—AKR1B1—uterine cancer	0.000138	0.00151	CbGpPWpGaD
Trimethoprim—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000138	0.000755	CcSEcCtD
Trimethoprim—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	0.000137	0.00151	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000137	0.0015	CbGpPWpGaD
Trimethoprim—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	0.000136	0.00149	CbGpPWpGaD
Trimethoprim—Hypersensitivity—Epirubicin—uterine cancer	0.000134	0.000735	CcSEcCtD
Trimethoprim—Urticaria—Doxorubicin—uterine cancer	0.000134	0.000734	CcSEcCtD
Trimethoprim—Body temperature increased—Doxorubicin—uterine cancer	0.000133	0.00073	CcSEcCtD
Trimethoprim—Abdominal pain—Doxorubicin—uterine cancer	0.000133	0.00073	CcSEcCtD
Trimethoprim—TYMS—Circadian rythm related genes—PTEN—uterine cancer	0.000131	0.00144	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.00013	0.00143	CbGpPWpGaD
Trimethoprim—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	0.00013	0.00142	CbGpPWpGaD
Trimethoprim—Pruritus—Epirubicin—uterine cancer	0.000129	0.000706	CcSEcCtD
Trimethoprim—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000127	0.0014	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDKN2B—uterine cancer	0.000127	0.00139	CbGpPWpGaD
Trimethoprim—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	0.000126	0.00138	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—BIRC5—uterine cancer	0.000126	0.00138	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—EP300—uterine cancer	0.000125	0.00137	CbGpPWpGaD
Trimethoprim—Diarrhoea—Epirubicin—uterine cancer	0.000124	0.000683	CcSEcCtD
Trimethoprim—DHFR—Metabolism—POLD1—uterine cancer	0.000124	0.00136	CbGpPWpGaD
Trimethoprim—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	0.000124	0.00136	CbGpPWpGaD
Trimethoprim—Hypersensitivity—Doxorubicin—uterine cancer	0.000124	0.00068	CcSEcCtD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000124	0.00136	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.000123	0.00135	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—BIRC5—uterine cancer	0.000122	0.00134	CbGpPWpGaD
Trimethoprim—Dizziness—Epirubicin—uterine cancer	0.00012	0.00066	CcSEcCtD
Trimethoprim—DHFR—Disease—DCN—uterine cancer	0.00012	0.00132	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.00012	0.00131	CbGpPWpGaD
Trimethoprim—Pruritus—Doxorubicin—uterine cancer	0.000119	0.000653	CcSEcCtD
Trimethoprim—DHFR—Metabolism—AKR1C1—uterine cancer	0.000116	0.00127	CbGpPWpGaD
Trimethoprim—Vomiting—Epirubicin—uterine cancer	0.000116	0.000635	CcSEcCtD
Trimethoprim—Diarrhoea—Doxorubicin—uterine cancer	0.000115	0.000632	CcSEcCtD
Trimethoprim—Rash—Epirubicin—uterine cancer	0.000115	0.000629	CcSEcCtD
Trimethoprim—Dermatitis—Epirubicin—uterine cancer	0.000115	0.000629	CcSEcCtD
Trimethoprim—Headache—Epirubicin—uterine cancer	0.000114	0.000625	CcSEcCtD
Trimethoprim—Dizziness—Doxorubicin—uterine cancer	0.000111	0.000611	CcSEcCtD
Trimethoprim—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	0.000111	0.00122	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.000111	0.00122	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00011	0.0012	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00011	0.0012	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—BIRC5—uterine cancer	0.00011	0.0012	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—POLD1—uterine cancer	0.000108	0.00119	CbGpPWpGaD
Trimethoprim—Nausea—Epirubicin—uterine cancer	0.000108	0.000593	CcSEcCtD
Trimethoprim—Vomiting—Doxorubicin—uterine cancer	0.000107	0.000587	CcSEcCtD
Trimethoprim—DHFR—Disease—AKR1C3—uterine cancer	0.000107	0.00117	CbGpPWpGaD
Trimethoprim—Rash—Doxorubicin—uterine cancer	0.000106	0.000582	CcSEcCtD
Trimethoprim—Dermatitis—Doxorubicin—uterine cancer	0.000106	0.000582	CcSEcCtD
Trimethoprim—Headache—Doxorubicin—uterine cancer	0.000105	0.000579	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.000105	0.00115	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HMGA1—uterine cancer	0.000104	0.00114	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—RRM2—uterine cancer	0.000104	0.00114	CbGpPWpGaD
Trimethoprim—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	0.000103	0.00112	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—AKR1C1—uterine cancer	0.000101	0.00111	CbGpPWpGaD
Trimethoprim—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	0.000101	0.00111	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000101	0.00111	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—DCN—uterine cancer	0.000101	0.0011	CbGpPWpGaD
Trimethoprim—Nausea—Doxorubicin—uterine cancer	0.0001	0.000549	CcSEcCtD
Trimethoprim—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	9.76e-05	0.00107	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	9.65e-05	0.00106	CbGpPWpGaD
Trimethoprim—DHFR—Disease—FBXW7—uterine cancer	9.52e-05	0.00104	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—CXCL8—uterine cancer	9.51e-05	0.00104	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CYP11A1—uterine cancer	9.47e-05	0.00104	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	9.41e-05	0.00103	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	9.33e-05	0.00102	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CDKN2A—uterine cancer	9.3e-05	0.00102	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	9.19e-05	0.00101	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	9.1e-05	0.000998	CbGpPWpGaD
Trimethoprim—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	9.06e-05	0.000993	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	9.05e-05	0.000992	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—RRM2—uterine cancer	9.04e-05	0.000991	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—TP53—uterine cancer	8.96e-05	0.000982	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—AKR1C3—uterine cancer	8.95e-05	0.000981	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	8.94e-05	0.00098	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	8.94e-05	0.00098	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	8.92e-05	0.000977	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—DCN—uterine cancer	8.78e-05	0.000962	CbGpPWpGaD
Trimethoprim—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	8.56e-05	0.000938	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDKN2A—uterine cancer	8.32e-05	0.000912	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CYP11A1—uterine cancer	8.27e-05	0.000906	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CDKN1B—uterine cancer	8.24e-05	0.000903	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDKN2A—uterine cancer	8.12e-05	0.00089	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	8.07e-05	0.000884	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	7.88e-05	0.000864	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—AKR1C3—uterine cancer	7.81e-05	0.000856	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—VEGFA—uterine cancer	7.72e-05	0.000846	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CDKN2B—uterine cancer	7.46e-05	0.000818	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDKN1B—uterine cancer	7.37e-05	0.000807	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDKN2A—uterine cancer	7.26e-05	0.000795	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—EP300—uterine cancer	7.23e-05	0.000793	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDKN1B—uterine cancer	7.19e-05	0.000788	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CYP19A1—uterine cancer	6.97e-05	0.000764	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—STK11—uterine cancer	6.97e-05	0.000764	CbGpPWpGaD
Trimethoprim—DHFR—Disease—SMAD3—uterine cancer	6.81e-05	0.000747	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SRD5A2—uterine cancer	6.77e-05	0.000742	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NDUFB11—uterine cancer	6.77e-05	0.000742	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	6.76e-05	0.000741	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	6.74e-05	0.000739	CbGpPWpGaD
Trimethoprim—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	6.67e-05	0.000731	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	6.57e-05	0.000721	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	6.56e-05	0.000719	CbGpPWpGaD
Trimethoprim—DHFR—Disease—FGFR2—uterine cancer	6.5e-05	0.000712	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—EP300—uterine cancer	6.47e-05	0.000709	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDKN1B—uterine cancer	6.43e-05	0.000704	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—EP300—uterine cancer	6.31e-05	0.000692	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MTHFR—uterine cancer	6.25e-05	0.000685	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	6.21e-05	0.00068	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CYP19A1—uterine cancer	6.08e-05	0.000667	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—STK11—uterine cancer	6.08e-05	0.000667	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SRD5A2—uterine cancer	5.9e-05	0.000646	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NDUFB11—uterine cancer	5.9e-05	0.000646	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	5.69e-05	0.000624	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—EP300—uterine cancer	5.64e-05	0.000619	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SRD5A2—uterine cancer	5.51e-05	0.000604	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NDUFB11—uterine cancer	5.51e-05	0.000604	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.35e-05	0.000586	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—MTHFR—uterine cancer	5.24e-05	0.000574	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.05e-05	0.000554	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	4.95e-05	0.000542	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—AKR1B1—uterine cancer	4.89e-05	0.000536	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—STAR—uterine cancer	4.89e-05	0.000536	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.84e-05	0.00053	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—TP53—uterine cancer	4.63e-05	0.000507	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	4.58e-05	0.000502	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—MTHFR—uterine cancer	4.57e-05	0.000501	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	4.33e-05	0.000474	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—AKR1B1—uterine cancer	4.26e-05	0.000467	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—STAR—uterine cancer	4.26e-05	0.000467	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	4.22e-05	0.000462	CbGpPWpGaD
Trimethoprim—DHFR—Disease—ERBB2—uterine cancer	4.08e-05	0.000447	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—TP53—uterine cancer	4.04e-05	0.000443	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	4.02e-05	0.000441	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—AKR1B1—uterine cancer	3.98e-05	0.000437	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—STAR—uterine cancer	3.98e-05	0.000437	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.94e-05	0.000431	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—POLD1—uterine cancer	3.84e-05	0.000421	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	3.81e-05	0.000418	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CDKN1B—uterine cancer	3.78e-05	0.000414	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NDUFB11—uterine cancer	3.63e-05	0.000398	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SRD5A2—uterine cancer	3.63e-05	0.000398	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—AKR1C1—uterine cancer	3.59e-05	0.000394	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CTNNB1—uterine cancer	3.57e-05	0.000391	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PTEN—uterine cancer	3.48e-05	0.000381	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—POLD1—uterine cancer	3.35e-05	0.000367	CbGpPWpGaD
Trimethoprim—DHFR—Disease—EP300—uterine cancer	3.32e-05	0.000364	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	3.24e-05	0.000355	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—RRM2—uterine cancer	3.2e-05	0.000351	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—AKR1C1—uterine cancer	3.13e-05	0.000343	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—POLD1—uterine cancer	3.13e-05	0.000343	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—DCN—uterine cancer	3.11e-05	0.000341	CbGpPWpGaD
Trimethoprim—DHFR—Disease—NRAS—uterine cancer	3.1e-05	0.00034	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	2.98e-05	0.000326	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP11A1—uterine cancer	2.93e-05	0.000321	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—AKR1C1—uterine cancer	2.92e-05	0.00032	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PTEN—uterine cancer	2.91e-05	0.000319	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	2.88e-05	0.000316	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—RRM2—uterine cancer	2.79e-05	0.000306	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—EP300—uterine cancer	2.78e-05	0.000305	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—AKR1C3—uterine cancer	2.77e-05	0.000303	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—DCN—uterine cancer	2.71e-05	0.000297	CbGpPWpGaD
Trimethoprim—DHFR—Disease—KRAS—uterine cancer	2.67e-05	0.000293	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—STAR—uterine cancer	2.63e-05	0.000288	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—AKR1B1—uterine cancer	2.63e-05	0.000288	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—RRM2—uterine cancer	2.61e-05	0.000286	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP11A1—uterine cancer	2.55e-05	0.00028	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PTEN—uterine cancer	2.54e-05	0.000279	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—DCN—uterine cancer	2.53e-05	0.000277	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PIK3CA—uterine cancer	2.45e-05	0.000269	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.43e-05	0.000266	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—EP300—uterine cancer	2.42e-05	0.000266	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—AKR1C3—uterine cancer	2.41e-05	0.000264	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP11A1—uterine cancer	2.38e-05	0.000261	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HRAS—uterine cancer	2.27e-05	0.000249	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—AKR1C3—uterine cancer	2.25e-05	0.000247	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—STK11—uterine cancer	2.15e-05	0.000236	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP19A1—uterine cancer	2.15e-05	0.000236	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—POLD1—uterine cancer	2.06e-05	0.000226	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CA—uterine cancer	2.06e-05	0.000225	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.02e-05	0.000222	CbGpPWpGaD
Trimethoprim—DHFR—Disease—AKT1—uterine cancer	2.01e-05	0.00022	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.93e-05	0.000211	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.93e-05	0.000211	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—STK11—uterine cancer	1.88e-05	0.000206	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP19A1—uterine cancer	1.88e-05	0.000206	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CA—uterine cancer	1.79e-05	0.000197	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—STK11—uterine cancer	1.75e-05	0.000192	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP19A1—uterine cancer	1.75e-05	0.000192	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—RRM2—uterine cancer	1.72e-05	0.000188	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—AKT1—uterine cancer	1.68e-05	0.000184	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—DCN—uterine cancer	1.67e-05	0.000183	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.65e-05	0.00018	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—MTHFR—uterine cancer	1.62e-05	0.000177	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.57e-05	0.000172	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.57e-05	0.000172	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.48e-05	0.000163	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—AKT1—uterine cancer	1.47e-05	0.000161	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.43e-05	0.000156	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—MTHFR—uterine cancer	1.41e-05	0.000155	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—MTHFR—uterine cancer	1.32e-05	0.000144	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.16e-05	0.000127	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—STK11—uterine cancer	1.16e-05	0.000127	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.16e-05	0.000127	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTEN—uterine cancer	9.01e-06	9.87e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—MTHFR—uterine cancer	8.69e-06	9.52e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—EP300—uterine cancer	8.59e-06	9.41e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTEN—uterine cancer	7.85e-06	8.6e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—EP300—uterine cancer	7.48e-06	8.2e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTEN—uterine cancer	7.33e-06	8.03e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—EP300—uterine cancer	6.99e-06	7.66e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CA—uterine cancer	6.35e-06	6.96e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CA—uterine cancer	5.53e-06	6.07e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—AKT1—uterine cancer	5.19e-06	5.69e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CA—uterine cancer	5.17e-06	5.67e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTEN—uterine cancer	4.83e-06	5.3e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—EP300—uterine cancer	4.61e-06	5.05e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—AKT1—uterine cancer	4.52e-06	4.96e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—AKT1—uterine cancer	4.22e-06	4.63e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CA—uterine cancer	3.41e-06	3.74e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—AKT1—uterine cancer	2.79e-06	3.05e-05	CbGpPWpGaD
